Argenx to Buy Forte Biosciences for $2.2 Billion
The deal to acquire the Nasdaq-listed Forte represents a 41% premium to its closing price on Friday.
Connecting Global Economies
Flash News
How to watch the men’s Citi Open: Streaming options for the Round of 32
The former military chief aiming to unseat Netanyahu in Israel
Paul Thomas Anderson, Maya Rudolph Private World With 4 Kids
Xabi Alonso backs Morgan Rogers to make an ‘instant impact’ at Chelsea
Argenx to Buy Forte Biosciences for $2.2 Billion
How Sussex are helping plug cricket’s state-school talent drain
Apple leak in India, China eyes Indonesia for mineral access: 5 weekend reads you missed
Why Trump’s new tariff blitz is different this time round
Why Arsenal need a player like Vinicius Junior
Shooting at Seattle food festival leaves 2 dead, 5 injured
Monday, July 27, 2026